For example, an elevated expression of TRIM11 correlates with poor prognosis in HCC patients and exerts its oncogenic effect in HCC by downregulating p53 both in vitro and in vivo (13, 14). This evidence concerns the gene TP53 and hepatocellular carcinoma.